NCT00503776 2017-06-20Chemo/XRT +/- Amifostine to Assess Outcomes Related to Xerostomia, Mucositis, & DysphagiaVanderbilt-Ingram Cancer CenterPhase 2 Terminated41 enrolled 12 charts
NCT00409331 2012-08-07Amifostine With IMRT for Submandibular and Sublingual Salivary Sparing During Head and Neck Cancer TreatmentM.D. Anderson Cancer CenterPhase 2 Terminated3 enrolled 2 charts